Abstract
AbstractCurrently, with the knowledge of the role of collateral circulation in the development of cerebral ischaemia, traditional therapeutic windows are being prolonged, with time not being the only criterion. Instead, a more personalised approach is applied to select additional patients who might benefit from active treatment. This review briefly describes the current knowledge of the pathophysiology of the development of early ischaemic changes, the capabilities of MRI to depict such changes, and the basics of the routinely used imaging techniques broadly available for the assessment of individual phases of cerebral ischaemia, and summarises the possible clinical use of routine MR imaging, including patient selection for active treatment and assessment of the outcome on the basis of imaging.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Neurology (clinical),Radiology, Nuclear Medicine and imaging
Reference63 articles.
1. WHO (2020) WHO methods and data sources for country-level causes of death 2000-2019. World Health Organization, Geneva
2. Prayson RA, Yeaney G (2022) Neuropathology. A volume in the series: foundations in diagnostic pathology, 3rd edn. Elsevier, Philadeplhia, pp 40–76
3. Pekny M, Pekna M (2016) Reactive gliosis in the pathogenesis of CNS diseases. Biochim Biophys Acta Mol Basis Dis 1862:483–491. https://doi.org/10.1016/j.bbadis.2015.11.014
4. Ho M-L, Rojas R, Eisenberg RL (2012) Cerebral edema. AJR Am J Roentgenol 199:W258–W273. https://doi.org/10.2214/AJR.11.8081
5. Kaufmann AM, Firlik AD, Fukui MB et al (1998) Ischemic core and penumbra in human stroke. Stroke 30:93–99. https://doi.org/10.1161/01.STR.30.1.93
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献